BLAINJECTIONINJECTABLE
Approved
Oct 2018
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
4/8 — Partial
REVCOVI (elapegademase-lvlr) by Chiesi. Approved for adenosine deaminase severe combined immunodeficiency. First approved in 2018.
Drug data last refreshed 18h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
REVCOVI (elapegademase-lvlr) is an injectable enzyme replacement therapy developed by Chiesi and approved by the FDA on October 5, 2018. Data on specific indications and mechanism of action are not available in the provided dataset. The product is classified as a biologics license application (BLA) and represents an important therapeutic option in its disease category.
$0.0BPart D
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Clinical Trials (1)
Registry Study of Revcovi Treatment in Patients With ADA-SCID
Started Sep 2019
32 enrolled
Adenosine Deaminase Severe Combined Immunodeficiency
Career Relevance
REVCOVI's specialized therapeutic profile typically requires medical science liaisons, specialty pharmacy coordinators, and rare disease specialists for market support. Currently, there are zero open positions linked to this product in available job market data. Professionals in this space need expertise in rare disease management, healthcare economics, and specialized patient support programs.
Worked on REVCOVI at Chiesi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.